Proactive Investors - Run By Investors For Investors

Holista CollTech cracks formula to produce white bread with low GI level

Holista CollTech cracks formula to produce white bread with low GI level

Australian biotechnology company, Holista Colltech (ASX:HCT) has confirmed that a mix of natural ingredients has been shown to significantly reduce blood sugar levels caused by consuming white bread and other bakery products.

A clinical study on the ingredients was carried out at a leading Australian university in December 2015, with Hollista's proprietary GI Lite formulae and Veripan’s natural sourdough PANATURA® achieved a Glycemic Index (GI) reading of 53, the lowest level ever achieved worldwide in a clean-label white bread.

GI is an indicator of the ability of different types of foods that contain carbohydrate to raise the blood glucose.

A high GI score contain rapidly digested carbohydrates that can trigger a large and rapid rise in the level of blood glucose and potentially the insulin level.

Switzerland-based Veripan AG is Europe's largest independent supplier of specialty bakery ingredients.

The GI formulae, made from extracts of okra (ladies' fingers), dhal (lentils), barley and fenugreek – and Veripan’s natural sourdough PANATURA® provided the breakthrough.

The Australian university research team has been at the forefront of GI research for over a decade, and has determined the GI values of more than 2,500 foods.

Holista and Veripan will jointly distribute the PANATURA® GI which is believed to be the world’s first clean-label low GI White Bread.

Using PANATURA® GI is expected to add a marginal increase to the cost of production and the ingredients will comprise approximately 5-7% of the total flour mix.

The global white bread market is worth an estimated US$170 billion. Rollout will be in Australia first followed by Europe, North America China, India and the rest of Asia.

Overall, the results are highly promising for Hollista given the propensity for white bread consumption in western countries as well as the desire for healthier diets.



Proactive Investors is a global leader reporting financial news, media, research and hosts events for listed emerging growth companies and investors across four continents.



View full HCT profile View Profile

Holista Colltech Ltd Timeline

September 19 2017

Related Articles

December 03 2018
Since September, the group's portfolio has steamed ahead with a number of new and successful clinical trials, as well as a boost from the float of one of its companies on the Nasdaq
Nemaura Medical Inc CEO Dr Faz Chowdhury
November 06 2018
The medtech company is eying explosive growth with sugarBEAT, on the cusp of launching in the UK, followed by the rest of Europe in 2018
October 18 2018
Sativa Investments has taken a big step towards becoming the UK's first seed to consumer medicinal cannabis business

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use